Herbert Yu

23.1k citations

254 papers · 12.1k indexed · 2 hit papers · h-index 62

Impact in

Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 0.5%
- Cancer Risks and Factors

Papers in ⓘ

Cancer Research 77
- Cancer-related molecular mechanisms research 40
- Cancer, Lipids, and Metabolism 18
Endocrinology, Diabetes and Metabolism 59
- Growth Hormone and Insulin-like Growth Factors 47

Co-authors: Lingeng Lu (44 shared papers)Dionyssios Katsaros (47 shared papers)Biyun Qian (42 shared papers)Harvey A. Risch (35 shared papers)Xiaomei Ma (5 shared papers)Melinda L. Irwin (15 shared papers)Irene A. Rigault de la Longrais (14 shared papers)Thomas Rutherford (13 shared papers)
Journals: Cancer Research (15 papers)Breast Cancer Research and Treatment (13 papers)Cancer Epidemiology Biomarkers & Prevention (12 papers)Scientific Reports (8 papers)International Journal of Cancer (8 papers)
Partner nations: United States China Italy

In The Last Decade

Herbert Yu

249 papers receiving 11.8k citations

Hit Papers

align trajectories log scale

A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 2018 · 402 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Cancer Research
2000 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by Herbert Yu

Since Specialization

Citations

This map shows the geographic impact of Herbert Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Yu more than expected).

Fields of papers citing papers by Herbert Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Yu. The network helps show where Herbert Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Herbert Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Herbert Yu Line = papers co-authored together Herbert Yu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression JNCI Journal of the National Cancer Institute ·Herbert Yu Hit paper breakdown →	2000	1158
2	A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 Cancer Research ·Chao Mao, Xiang Wang, Yating Liu, Min Wang, Bin Yan, Yiqun Jiang, Yongyong Shi, Yi Shen, Xiaoli Liu, Weiwei Lai, Rui Yang, Desheng Xiao, Yan Cheng, Shuang Liu, Hu Zhou, Ya Cao, Weishi Yu, Kathrin Muegge, Herbert Yu, Yongguang Tao Hit paper breakdown →	2018	402
3	Diagnostic Markers for Early Detection of Ovarian Cancer Clinical Cancer Research ·Irene Visintin, Ziding Feng, Gary Longton, David C. Ward, Ayesha B. Alvero, Yinglei Lai, Jeannette L. Tenthorey, Aliza Leiser, Ruben Flores-Saaib, Herbert Yu, Masoud Azori, Thomas Rutherford, Peter E. Schwartz, Gil Mor	2008	307
4	Physicians’ Weight Loss Counseling in Two Public Hospital Primary Care Clinics Academic Medicine ·Jian Huang, Herbert Yu, Estela Marin, Stephanie L. Brock, Donna L. Carden, Terry C. Davis	2004	242
5	Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis Cancer Research ·Lingeng Lu, Dionyssios Katsaros, Irene A. Rigault de la Longrais, Olga Sochirca, Herbert Yu	2007	240
6	Global burden of cancer. PubMed ·Xiaomei Ma, Herbert Yu	2006	227
7	A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer Cancer Epidemiology Biomarkers & Prevention ·Marc J. Gunter, Donald R. Hoover, Herbert Yu, Sylvia Wassertheil‐Smoller, JoAnn E. Manson, Jixin Li, Tiffany G. Harris, Thomas E. Rohan, XiaoNan Xue, Gloria Ho, Mark H. Einstein, Robert C. Kaplan, Robert D. Burk, Judith Wylie‐Rosett, Michaël Pollak, Garnet L. Anderson, Barbara V. Howard, Howard D. Strickler	2008	216
8	High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1 Breast Cancer Research and Treatment ·Biyun Qian, Dionyssios Katsaros, Lingeng Lu, Mario Preti, Antonio Durando, Riccardo Arisio, Lina Mu, Herbert Yu	2008	213
9	Randomized Controlled Trial of Aerobic Exercise on Insulin and Insulin-like Growth Factors in Breast Cancer Survivors: The Yale Exercise and Survivorship Study Cancer Epidemiology Biomarkers & Prevention ·Melinda L. Irwin, Katie Varma, Marty Alvarez-Reeves, Lisa Cadmus, Andrew Wiley, Gina G. Chung, Loretta DiPietro, Susan T. Mayne, Herbert Yu	2009	200
10	Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal Women Cancer Research ·Marc J. Gunter, Donald R. Hoover, Herbert Yu, Sylvia Wassertheil‐Smoller, Thomas E. Rohan, JoAnn E. Manson, Barbara V. Howard, Judith Wylie‐Rosett, Garnet L. Anderson, Gloria Ho, Robert C. Kaplan, Jixin Li, Xiaonan Xue, Tiffany G. Harris, Robert D. Burk, Howard D. Strickler	2008	176
11	Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation Journal of Clinical Laboratory Analysis ·Herbert Yu, Jehangir Mistry, Michael J. Nicar, M. Javad Khosravi, Anastasia Diamandis, Jaap van Doorn, Anders Juul	1999	156
12	Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. PubMed ·Herbert Yu, M Giai, Eleftherios P. Diamandis, Dionyssios Katsaros, D. J. Sutherland, Michael A. Levesque, Riccardo Roagna, Riccardo Ponzone, P Sismondi	1995	156
13	Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer Breast Cancer Research and Treatment ·Lingeng Lu, Guangjian Zhu, Chong Zhang, Qian Deng, Dionyssios Katsaros, Susan T. Mayne, Harvey A. Risch, Lina Mu, Emilie Marion Canuto, G. Gregori, Chiara Benedetto, Herbert Yu	2012	155
14	Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecologic Oncology ·Michael Kelly, David M. O’Malley, Pei Hui, Jessica N. McAlpine, Herbert Yu, Thomas Rutherford, Masoud Azodi, Peter E. Schwartz	2005	153
15	D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer OncoTargets and Therapy ·Xiao Yu, Hongyan Lin, Yu Wang, Wenwen Lv, Shuo Zhang, Ying Qian, Xiaobei Deng, Nannan Feng, Herbert Yu, Biyun Qian	2018	152
16	Exercise Improves Body Fat, Lean Mass, and Bone Mass in Breast Cancer Survivors Obesity ·Melinda L. Irwin, Marty Alvarez-Reeves, Lisa Cadmus, Eileen Mierzejewski, Susan T. Mayne, Herbert Yu, Gina G. Chung, Beth A. Jones, M. Tish Knobf, Loretta DiPietro	2009	141
17	Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials Psycho-Oncology ·Lisa Cadmus, Peter Salovey, Herbert Yu, Gina G. Chung, Stanislav V. Kasl, Melinda L. Irwin	2009	137
18	MiR-195 suppresses non-small cell lung cancer by targeting CHEK1 Oncotarget ·Ben Liu, Jinli Qu, Fangxiu Xu, Yan Guo, Yu Wang, Herbert Yu, Biyun Qian	2015	124
19	ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case-Control Study JNCI Journal of the National Cancer Institute ·H. A. Risch, Herbert Yu, Lingeng Lu, Mark Kidd	2010	116
20	Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk Lung Cancer ·Biyun Qian, Huan Zhang, Lína Zhang, Xiaoying Zhou, Herbert Yu, Kexin Chen	2010	116

About Herbert Yu

Herbert Yu is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology, Reproductive Medicine and Obstetrics and Gynecology, having authored 254 papers that have together received 12.1k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (47 papers), Cancer-related molecular mechanisms research (40 papers), RNA modifications and cancer (30 papers), Cancer Risks and Factors (30 papers), Metabolism, Diabetes, and Cancer (29 papers), Epigenetics and DNA Methylation (19 papers), Cancer, Lipids, and Metabolism (18 papers) and Ovarian cancer diagnosis and treatment (18 papers). The work is most often cited by research in Cancer Research (3.6k citations), Oncology (3.6k citations), Endocrinology, Diabetes and Metabolism (2.1k citations), Reproductive Medicine (804 citations) and Molecular Biology (6.0k citations). Herbert Yu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Lingeng Lu, Dionyssios Katsaros, Biyun Qian, Harvey A. Risch, Xiaomei Ma, Melinda L. Irwin, Irene A. Rigault de la Longrais, Thomas Rutherford, Hans J. Berkel and Susan T. Mayne. Their work appears in journals such as Cancer Research, Breast Cancer Research and Treatment, Cancer Epidemiology Biomarkers & Prevention, Scientific Reports and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact